Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2005, Vol. 105, No. 6, pp. 2392-2399.
Prepublished online as a Blood First Edition Paper on November 18, 2004; DOI 10.1182/blood-2004-06-2435.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-06-2435v1
105/6/2392    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirakawa, S.
Right arrow Articles by Detmar, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirakawa, S.
Right arrow Articles by Detmar, M.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 28, 2004
Accepted November 16, 2004

Vascular endothelial growth factor promotes sensitivity to ultraviolet-B-induced cutaneous photodamage

Satoshi Hirakawa, Seishiro Fujii, Kentaro Kajiya, Kiichiro Yano, and Michael Detmar*

Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
Shiseido Life Science Research Center, Yokohama, Japan
Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland

* Corresponding author; email: michael.detmar{at}pharma.ethz.ch.

Acute ultraviolet B (UVB) irradiation of the skin results in erythema, vasodilation, edema and angiogenesis, which is associated with the expression of vascular endothelial growth factor (VEGF) by epidermal keratinocytes. It is not clear, however, if VEGF is required for the damage and/or repair process that occurs in the skin upon UVB exposure. We subjected transgenic mice that overexpress VEGF, and their wild-type littermates, to graded doses of acute UVB irradiation. The skin of VEGF overexpressing mice was highly photosensitive, and became erythematic when exposed to half the UVB dose required to induce erythema in wild-type mice. Erythema was associated with proliferation of dermal endothelial cells, cutaneous edema, and inflammatory cell infiltration. When mice were subjected to 10 weeks of low-level UVB irradiation, no major changes were observed in wild-type mice, whereas VEGF transgenic mice developed skin damage with degradation of the dermal matrix and enhanced vascularization. Systemic treatment with an anti-VEGF blocking antibody reduced the sensitivity of wild-type mice to acute UVB irradiation, without inhibiting post-UVB repair. Our results reveal that VEGF promotes the cutaneous damage that occurs after UVB exposure, and that the VEGF signaling pathway might serve as a novel target for the prevention of UVB-induced photodamage.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

VEGF, sunburn, and wrinkles
Stephen C. Ekker
Blood 2005 105: 2246. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
C. Halin, H. Fahrngruber, J. G. Meingassner, G. Bold, A. Littlewood-Evans, A. Stuetz, and M. Detmar
Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
Am. J. Pathol., July 1, 2008; 173(1): 265 - 277.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, March 19, 2005; 330(7492): 680 - 680.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020